Article metrics
PDF
Other content recommended for you
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- Covid-19: Risk of cerebral blood clots from disease is 10 times that from vaccination, study finds
- Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
- Balancing benefits and potential risks of vaccination: the precautionary principle and the law of unintended consequences
- Healthcare workers’ perceptions and attitudes towards the UK’s COVID-19 vaccination programme: a rapid qualitative appraisal
- What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey
- The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy
- Covid-19: How AstraZeneca lost the vaccine PR war
- Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study